Evidence map›Paper›PMID 41746101›Full record

ArticleVaccines2026

Immunogenic Properties and Safety of a Quadrivalent Inactivated Subunit Adjuvanted Influenza Vaccine in Adults Aged 18 to 85 Years at the End of the COVID-19 Pandemic in the 2022-2023 Season.

Mikhail P Kostinov, Aristitsa M Kostinova, Sofia Iushkova, Lilia Gladkova, Anna Vlasenko, Yulia Dagil, Maria Kvasova, Anastasia Kameleva, Anastasia Kachnova, Irina Solovеva and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Mikhail P KostinovDepartment of Epidemiology and Modern Vaccination Technologies, I. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119991, Russia.ORCID 0000-0002-1382-9403
Aristitsa M KostinovaDepartment of Epidemiology and Modern Vaccination Technologies, I. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119991, Russia.ORCID 0000-0002-0584-2376
Sofia IushkovaDepartment of Epidemiology and Modern Vaccination Technologies, I. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119991, Russia.
Lilia GladkovaMoscow Health Department, D. D. Pletnev City Clinical Hospital, Moscow 105077, Russia.
Anna VlasenkoFederal State Budgetary Educational Institution of Higher Education, Samara State Medical University, The Ministry of Healthcare of the Russian Federation, Samara 443079, Russia.ORCID 0000-0001-6454-4216
Yulia DagilNational Research Center, Institute of Immunology of the Federal Medical Biological Agency of Russia, Moscow 115522, Russia.ORCID 0000-0001-9320-0789
Maria KvasovaFederal State Budgetary Educational Institution of Higher Education, Privolzhsky Research Medical University, Ministry of Health of the Russian Federation, Nizhniy Novgorod 603005, Russia.ORCID 0000-0002-2244-0256
Anastasia KamelevaMoscow Health Department, D. D. Pletnev City Clinical Hospital, Moscow 105077, Russia.ORCID 0000-0002-5895-2982
Anastasia KachnovaMoscow Health Department, D. D. Pletnev City Clinical Hospital, Moscow 105077, Russia.
Irina SolovеvaDepartment of Pediatrics, Institute of Medicine, Ecology and Physical Culture, Ulyanovsk State University, Federal State Budgetary Educational Institution of Higher Education, Ulyanovsk 432007, Russia.
Anna KhamidulinaDepartment of Pediatrics, Institute of Medicine, Ecology and Physical Culture, Ulyanovsk State University, Federal State Budgetary Educational Institution of Higher Education, Ulyanovsk 432007, Russia.
Ekaterina PrutskovaDepartment of Pediatrics, Institute of Medicine, Ecology and Physical Culture, Ulyanovsk State University, Federal State Budgetary Educational Institution of Higher Education, Ulyanovsk 432007, Russia.
Irina MekhantsevaDepartment of Internal Medicine, Karaganda Medical University, Karaganda 100012, Kazakhstan.ORCID 0000-0001-6601-8172
Natalia AndreevaDepartment of Healthcare Management and Economics, The Chuvash State University Named After I. N. Ulyanov, Federal State Educational Establishment of Higher Professional Education, Cheboksary 428015, Russia.
Valentina B PolishchukI. I. Mechnikov Research Institute of Vaccines and Sera, Moscow 105064, Russia.
Yvette Albahansa ManaDepartment of Epidemiology and Modern Vaccination Technologies, I. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119991, Russia.
Anton M KostinovI. I. Mechnikov Research Institute of Vaccines and Sera, Moscow 105064, Russia.ORCID 0000-0001-9665-1382

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adjuvanted influenza vaccineadultsazoximer bromideimmunogenicityinfluenzaSARS-CoV-2 infectionvaccination

Identifiers

PMID41746101
PMCPMC12945232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.